Hyderabad : Amid questions raised by industry experts and opposition parties on the emergency approval to its coronavirus vaccine Covaxin without publication of efficacy data, Bharat Biotech’s chairman on Monday hit out at critics saying his firm had carried out ”200 per cent honest clinical trials”. Speaking to reporters at a virtual press conference, Krishna Ella said his firm has a […]
Read MoreNew Delhi: Union Science and Technology Minister Harsh Vardhan on Monday said the Herculean efforts of scientists have finally paid off as two coronavirus vaccines have been developed at a record-breaking speed and granted authorisation in India. Vardhan, who also holds the charge of Union Health Ministry, said new diagnostic tests can detect the virus within minutes. Massive open science […]
Read MoreMumbai: Rising for the ninth straight session, the BSE Sensex closed above the 48,000-mark for the first time on Monday as investor sentiment got a boost after India approved two coronavirus vaccines over the weekend. A strengthening rupee, positive global cues and encouraging macroeconomic data gave further impetus to risk appetite, traders said. The 30-share BSE Sensex ended 307.82 […]
Read MoreNew Delhi: With some Congress leaders raising concerns over the grant of approval to Bharat Biotech‘s COVID-19 vaccine, Health Minister Harsh Vardhan asserted on Sunday that Covaxin is more likely to work against newer variants of the virus, including the UK variant, and asked politicians not to ”discredit well laid out science-backed protocols” followed for approving the jab. Some Congress leaders, […]
Read MoreLucknow: A dry run to assess the readiness of the mechanism laid out for the imminent COVID-19 immunisation drive will be undertaken in six sites of Uttar Pradesh from January 5, the state government said on Sunday. In a statement, the government said the dry run will start at 10 am in three urban and […]
Read More